Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 27Recruiting 10Unknown 9Terminated 3Not yet recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Lymphoid 1Gynecologic 1CNS 1

Conditions

Breast Neoplasms 544Triple Negative Breast Neoplasms 87Neoplasms 19Colorectal Neoplasms 19Lung Neoplasms 16Advanced Breast Cancer 16Neoplasm Metastasis 15Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Motor Activity 12Breast Cancer Lymphedema 12HER2-positive Breast Cancer 11Uterine Cervical Neoplasms 10Stomach Neoplasms 10Ovarian Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 10Anxiety Disorders 10Endometrial Neoplasms 9Depression 8Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Pain, Postoperative 6Pain 6Melanoma 6Lymphedema 6Head and Neck Neoplasms 6Colonic Neoplasms 6Cardiotoxicity 6Sarcoma 5Pancreatic Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Cognitive Dysfunction × Breast × Clear all
NCT06662474 2024-10-30

Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches

Grigore T. Popa University of Medicine and Pharmacy

Phase NA Not yet recruiting
120 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT06234150 2024-02-20

ADANC

The First Affiliated Hospital with Nanjing Medical University

Phase NA Not yet recruiting
90 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡